Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Imricor Medical Systems Q3 2026 Results: Net Loss of $2.91M, Loss Narrows

Imricor Medical Systems reported a net loss of $28.0 million for the nine months ended September 30, 2026, compared to a $16.6 million loss in the prior year period, driven by increased R&D and G&A expenses. Despite the loss, the company significantly strengthened its cash position to $62.1 million through common stock issuances and the maturity of marketable securities.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Net income-2.9-3.5
EPS (diluted, $ a share)$-0.02$-0.02

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Source

10-Q filed with the SEC, IMR. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Imricor Medical Systems, Inc.: key numbers

Shares outstanding
358.66MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Imricor Medical Systems, Inc.

All →
3:05 PM ET 8-K
Financial Results

Imricor Medical Systems Financial Results

Imricor Medical Systems reported Q3 2026 financial results, highlighted by a 437% year-over-year revenue increase to $188k as the company commenced its U.S. commercial launch. The company secured its first two U.S. hospital customers, Rady Children’s Hospital–San Diego and Children’s Medical Center Dallas, for its NorthStar system and established a strategic partnership with Philips for a turnkey cardiac iMR lab solution.

Term
Q3 2026

“The third quarter of 2026 is the quarter our U.S. commercial launch became real. Within weeks of launching Imricor Cardiovascular, two of the nation’s leading children’s hospitals, Rady Children’s Hospital in San Diego and Children’s Medical Center Dallas, committed to NorthStar to deliver completely radiation-free cardiac catheterisation for their patients.”

Steve Wedan, Executive Chair, President and CEO

“Children who need multiple heart procedures over their lives should not have to carry a lifetime of radiation exposure. The U.S. launch is where we begin to change that”

Steve Wedan, Executive Chair, President and CEO

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.